You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1181 GEN1042-mIgG2a, an Fc-inert mouse-human chimeric variant of GEN1042 (DuoBody®-CD40x4–1BB), exhibits in vivo antitumor activity and peripheral immune modulation

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immuno-Conjugates and Chimeric Molecules
1181 GEN1042-mIgG2a, an Fc-inert mouse-human chimeric variant of GEN1042 (DuoBody®-CD40x4–1BB), exhibits in vivo antitumor activity and peripheral immune modulation

 

Online download statistics by month:

Online download statistics by month: November 2023 to August 2025

AbstractFullPdf
Nov 2023242018
Dec 20234809
Jan 20245504
Feb 202480011
Mar 20249608
Apr 20246808
May 202411606
Jun 20249808
Jul 20245004
Aug 20245206
Sep 20245801
Oct 20244009
Nov 20247606
Dec 2024104012
Jan 202565018
Feb 20252804
Mar 20250014
Apr 2025002
May 2025004
Jun 2025105
Aug 2025100
Total12780157